PFIZER INC (PFE) vs Viatris Inc (VTRS)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | PFE | VTRS |
|---|---|---|
| Sector | Health Care | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $62.58B | $14.3B |
| Revenue growth (YoY) | ▼ 1.6% | ▼ 3.0% |
| Net income | $7.77B | -$3.51B |
| Gross margin | 74.3% | 35.1% |
| Diluted EPS | $1.36 | $-3.00 |
| Insider net (6 mo) | +109.6K sh • 2 sells • 3 buys | −35.3K sh • 1 sells • 0 buys |
| Institutional owners | 43 | 41 |
| Institutional value held | $61.91B | $10.77B |
| Next earnings (est.) | Nov 3, 2026 | Around Nov 5, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About PFIZER INC (PFE)
Pfizer Inc. is a research-based, global biopharmaceutical company incorporated in Delaware in 1942 that applies science and global resources to discover, develop, manufacture, market, sell and distribute biopharmaceutical products worldwide, operating across… Read more →
About Viatris Inc (VTRS)
Viatris is a global healthcare company formed in November 2020 through the combination of Mylan and Pfizer's Upjohn business, with a mission to empower people worldwide to live healthier at every stage of life regardless of geography or circumstance. Read more →
Source: SEC EDGAR.